Aerobic exercise regulates blood lipid and insulin resistance via the toll‑like receptor 4‑mediated extracellular signal‑regulated kinases/AMP‑activated protein kinases signaling pathway

Wang,Mei; Li,Sen; Wang,Fubaihui; Zou,Jinhui; Zhang,Yanfeng

doi:10.3892/mmr.2018.8863

Aerobic exercise regulates blood lipid and insulin resistance via the toll‑like receptor 4‑mediated extracellular signal‑regulated kinases/AMP‑activated protein kinases signaling pathway

Authors:
- Mei Wang
- Sen Li
- Fubaihui Wang
- Jinhui Zou
- Yanfeng Zhang
View Affiliations

Affiliations: State General Administration of Sports, Sports Science Institute, Mass Sports Research Center, Beijing 100061, P.R. China, Jiangsu Institute of Sports Science, Nanjing, Jiangsu 210033, P.R. China, Guangxi Institute of Sports Science Mass Sports Research, Nanning, Guangxi 210014, P.R. China
Published online on: April 11, 2018 https://doi.org/10.3892/mmr.2018.8863
Pages: 8339-8348

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Diabetes mellitus is a complicated metabolic disease with symptoms of hyperglycemia, insulin resistance, chronic damage and dysfunction of tissues, and metabolic syndrome for insufficient insulin production. Evidence has indicated that exercise treatments are essential in the progression of type‑ІІ diabetes mellitus, and affect insulin resistance and activity of islet β‑cells. In the present study, the efficacy and signaling mechanism of aerobic exercise on blood lipids and insulin resistance were investigated in the progression of type‑ІІ diabetes mellitus. Body weight, glucose metabolism and insulin serum levels were investigated in mouse models of type‑ІІ diabetes mellitus following experienced aerobic exercise. Expression levels of inflammatory factors, interleukin (IL)‑6, high‑sensitivity C‑reactive protein, tumor necrosis factor‑α and leucocyte differentiation antigens, soluble CD40 ligand in the serum were analyzed in the experimental mice. In addition, expression levels of toll‑like receptor 4 (TLR‑4) were analyzed in the liver cells of experimental mice. Changes of oxidative stress indicators, including reactive oxygen species, superoxide dismutase, glutathione and catalase were examined in the liver cells of experimental mice treated by aerobic exercise. Expression levels and activity of extracellular signal‑regulated kinases (ERK) and AMP‑activated protein kinase (AMPK) signaling pathways were investigated in the liver cells of mouse models of type‑ІІ diabetes mellitus after undergoing aerobic exercise. Aerobic exercise decreased the expression levels of inflammatory factors in the serum of mouse models of type‑ІІ diabetes mellitus. The results indicated that aerobic exercise downregulated oxidative stress indicators in liver cells from mouse models of type‑ІІ diabetes mellitus. In addition, the ERK and AMPK signaling pathways were inactivated by aerobic exercise in liver cells in mouse models of type‑ІІ diabetes mellitus. The activity of ERK and AMPK, and the function of islet β‑cells were observed to be improved in experimental mice treated with aerobic exercise. Furthermore, blood lipid metabolism and insulin resistance were improved by treatment with aerobic exercise. Body weight and glucose concentration of serology was markedly improved in mouse models of type‑ІІ diabetes mellitus. Furthermore, TLR‑4 inhibition markedly promoted ERK and AMPK expression levels and activity. Thus, these results indicate that aerobic exercise may improve blood lipid metabolism, insulin resistance and glucose plasma concentration in mouse models of type‑ІІ diabetes mellitus. Thus indicating aerobic exercise is beneficial for improvement of blood lipid and insulin resistance via the TLR‑4‑mediated ERK/AMPK signaling pathway in the progression of type‑ІІ diabetes mellitus.

View Figures

View References

1	Thomas MC, Paldánius PM, Ayyagari R, Ong SH and Groop PH: Systematic literature review of DPP-4 inhibitors in patients with type 2 diabetes mellitus and renal impairment. Diabetes Ther. 7:439–454. 2016. View Article : Google Scholar : PubMed/NCBI
2	Wu XY, Lam VC, Yu YF, Ho RS, Feng Y, Wong CH, Yip BH, Tsoi KK, Wong SY and Chung VC: Epidemiological characteristics and methodological quality of meta-analyses on diabetes mellitus treatment: A systematic review. Eur J Endocrinol. 175:353–360. 2016. View Article : Google Scholar : PubMed/NCBI
3	Hayes J, Anderson R and Stephens JW: Sitagliptin/metformin fixed-dose combination in type 2 diabetes mellitus: An evidence-based review of its place in therapy. Drug Des Devel Ther. 10:2263–2270. 2016. View Article : Google Scholar : PubMed/NCBI
4	Shen Y, Cai R, Sun J, Dong X, Huang R, Tian S and Wang S: Diabetes mellitus as a risk factor for incident chronic kidney disease and end-stage renal disease in women compared with men: A systematic review and meta-analysis. Endocrine. 55:66–76. 2017. View Article : Google Scholar : PubMed/NCBI
5	Byrne H, Caulfield B and De Vito G: Effects of self-directed exercise programmes on individuals with type 2 diabetes mellitus: A systematic review evaluating their effect on HbA1c and other metabolic outcomes, physical characteristics, cardiorespiratory fitness and functional outcomes. Sports Med. 47:717–733. 2017. View Article : Google Scholar : PubMed/NCBI
6	Chhabra L and Kowlgi NG: Low incidence of diabetes mellitus in coronary microvascular dysfunction: An intriguing association. JACC Cardiovasc Interv. 9:395–396. 2016. View Article : Google Scholar : PubMed/NCBI
7	Wan EY, Fong DY, Fung CS and Lam CL: Incidence and predictors for cardiovascular disease in Chinese patients with type 2 diabetes mellitus-a population-based retrospective cohort study. J Diabetes Complications. 30:444–450. 2016. View Article : Google Scholar : PubMed/NCBI
8	Latha R, Shanthi P and Sachdanandam P: Protective role of Kalpaamruthaa in type II diabetes mellitus-induced cardiovascular disease through the modulation of protease-activated receptor-1. Pharmacogn Mag. 11 Suppl 1:S209–S216. 2015. View Article : Google Scholar : PubMed/NCBI
9	Domingueti CP, Dusse LM, Carvalho Md, de Sousa LP, Gomes KB and Fernandes AP: Diabetes mellitus: The linkage between oxidative stress, inflammation, hypercoagulability and vascular complications. J Diabetes Complications. 30:738–745. 2016. View Article : Google Scholar : PubMed/NCBI
10	Liang Z, Wu Y, Zhu X, Fang Q and Chen D: Insulin resistance and lipid profile during an oral glucose tolerance test in women with and without gestational diabetes mellitus. J Obstet Gynaecol. 36:337–339. 2016. View Article : Google Scholar : PubMed/NCBI
11	Magri CJ, Fava S and Galea J: Prediction of insulin resistance in type 2 diabetes mellitus using routinely available clinical parameters. Diabetes Metab Syndr. 10 2 Suppl 1:S96–S101. 2016. View Article : Google Scholar : PubMed/NCBI
12	Martínez-Díaz-Guerra G, Guadalix S, Aramendi M, Librizzi S, García E, Jiménez C and Hawkins F: Serum levels of osteocalcin and insulin resistance in patients with impaired glucose tolerance or new-onset diabetes mellitus after liver transplantation. Horm Metab Res. 48:325–330. 2016. View Article : Google Scholar : PubMed/NCBI
13	Grineva E: Diabetes mellitus and cardiovascular disease: Strategies for prevention. Minerva Endocrinol. 41:401–402. 2016.PubMed/NCBI
14	Halimi JM, Joly D, Combe C, Choukroun G, Dussol B, Fauvel JP, Quéré S and Fiquet B: Blood pressure and proteinuria control remains a challenge in patients with type 2 diabetes mellitus and chronic kidney disease: Experience from the prospective observational ALICE-PROTECT study. BMC Nephrol. 17:1352016. View Article : Google Scholar : PubMed/NCBI
15	de Lima Thomaz H, Rosado Lopes E, Neves Ribeiro PA, Machado Corrêa Monteiro R, de Oliveira Mello L and Saunders C: Systematic review; Nutritional therapy in gestational diabetes mellitus. Nutr Hosp. 28:1806–1814. 2013.PubMed/NCBI
16	Lautatzis ME, Goulis DG and Vrontakis M: Efficacy and safety of metformin during pregnancy in women with gestational diabetes mellitus or polycystic ovary syndrome: A systematic review. Metabolism. 62:1522–1534. 2013. View Article : Google Scholar : PubMed/NCBI
17	Karalliedde J and Gnudi L: Diabetes mellitus, a complex and heterogeneous disease, and the role of insulin resistance as a determinant of diabetic kidney disease. Nephrol Dial Transplant. 31:206–213. 2016.PubMed/NCBI
18	Zhang L, Chen Y, Li C, Lin X, Cheng X and Li T: Protective effects of combined intervention with adenovirus vector mediated IL-10 and IGF-1 genes on endogenous islet β cells in nonobese diabetes mice with onset of type 1 diabetes mellitus. PLoS One. 9:e926162014. View Article : Google Scholar : PubMed/NCBI
19	Xu XW and Zhang DX: Effect of Tangyikang in improving the function of pancreatic islet beta cells in patients with latent autoimmune diabetes mellitus in adults. Zhongguo Zhong Xi Yi Jie He Za Zhi. 28:882–885. 2008.(In Chinese). PubMed/NCBI
20	Lei T, Tang W, Xiong Y, Di Y, Zhang K and Shu X: Association of TLR4 gene polymorphisms with susceptibility to type 2 diabetes mellitus in the Chinese Han population. Int Immunopharmacol. 24:68–71. 2015. View Article : Google Scholar : PubMed/NCBI
21	Shao L, Zhang P, Zhang Y and Ma A: Inflammatory unbalance of TLR3 and TLR4 in PCI patients with or without type 2 diabetes mellitus. Immunol Lett. 161:81–88. 2014. View Article : Google Scholar : PubMed/NCBI
22	Cheng S, So WY, Zhang D, Cheng Q, Boucher BJ and Leung PS: Calcitriol reduces hepatic triglyceride accumulation and glucose output through Ca²⁺/CaMKK&#;/AMPK activation under insulin-resistant conditions in type 2 diabetes mellitus. Curr Mol Med. 16:747–758. 2016. View Article : Google Scholar : PubMed/NCBI
23	Melling CW, Grisé KN, Hasilo CP, Fier B, Milne KJ, Karmazyn M and Noble EG: A model of poorly controlled type 1 diabetes mellitus and its treatment with aerobic exercise training. Diabetes Metab. 39:226–235. 2013. View Article : Google Scholar : PubMed/NCBI
24	Madsen A, Bjune JI, Bjørkhaug L, Mellgren G and Sagen JV: The cAMP-dependent protein kinase downregulates glucose-6-phosphatase expression through RORα and SRC-2 coactivator transcriptional activity. Mol Cell Endocrinol. 419:92–101. 2016. View Article : Google Scholar : PubMed/NCBI
25	Yamada E, Okada S, Bastie CC, Vatish M, Nakajima Y, Shibusawa R, Ozawa A, Pessin JE and Yamada M: Fyn phosphorylates AMPK to inhibit AMPK activity and AMP-dependent activation of autophagy. Oncotarget. 7:74612–74629. 2016. View Article : Google Scholar : PubMed/NCBI
26	Wojtaszewski JF, Mourtzakis M, Hillig T, Saltin B and Pilegaard H: Dissociation of AMPK activity and ACCbeta phosphorylation in human muscle during prolonged exercise. Biochem Biophys Res Commun. 298:309–316. 2002. View Article : Google Scholar : PubMed/NCBI
27	Schmitt S, Eberhagen C, Weber S, Aichler M and Zischka H: Isolation of mitochondria from cultured cells and liver tissue biopsies for molecular and biochemical analyses. Methods Mol Biol. 1295:87–97. 2015. View Article : Google Scholar : PubMed/NCBI
28	Riccalton-Banks L, Bhandari R, Fry J and Shakesheff KM: A simple method for the simultaneous isolation of stellate cells and hepatocytes from rat liver tissue. Mol Cell Biochem. 248:97–102. 2003. View Article : Google Scholar : PubMed/NCBI
29	Kamphuis W and Klooster J: Pseudo-immunolabelling with the avidin-biotin-peroxidase complex due to the presence of endogenous biotin in the retina. Methods Mol Biol. 418:129–138. 2008.PubMed/NCBI
30	Reid RD, Tulloch HE, Sigal RJ, Kenny GP, Fortier M, McDonnell L, Wells GA, Boulé NG, Phillips P and Coyle D: Effects of aerobic exercise, resistance exercise or both, on patient-reported health status and well-being in type 2 diabetes mellitus: A randomised trial. Diabetologia. 53:632–640. 2010. View Article : Google Scholar : PubMed/NCBI
31	Marcus RL, Smith S, Morrell G, Addison O, Dibble LE, Wahoff-Stice D and Lastayo PC: Comparison of combined aerobic and high-force eccentric resistance exercise with aerobic exercise only for people with type 2 diabetes mellitus. Phys Ther. 88:1345–1354. 2008. View Article : Google Scholar : PubMed/NCBI
32	Carolan-OIah MC: Educational and intervention programmes for gestational diabetes mellitus (GDM) management: An integrative review. Collegian. 23:103–114. 2016. View Article : Google Scholar : PubMed/NCBI
33	Fatone C, Guescini M, Balducci S, Battistoni S, Settequattrini A, Pippi R, Stocchi L, Mantuano M, Stocchi V and De Feo P: Two weekly sessions of combined aerobic and resistance exercise are sufficient to provide beneficial effects in subjects with type 2 diabetes mellitus and metabolic syndrome. J Endocrinol Invest. 33:489–495. 2010. View Article : Google Scholar : PubMed/NCBI
34	Peiris C: Supervised aerobic and resistance exercise improves glycaemic control and modifiable cardiovascular risk factors in people with type 2 diabetes mellitus. J Physiother. 57:1262011. View Article : Google Scholar : PubMed/NCBI
35	Kwon HR, Min KW, Ahn HJ, Seok HG, Lee JH, Park GS and Han KA: Effects of aerobic exercise vs. resistance training on endothelial function in women with type 2 diabetes mellitus. Diabetes Metab J. 35:364–373. 2011. View Article : Google Scholar : PubMed/NCBI
36	Bello AI, Owusu-Boakye E, Adegoke BO and Adjei DN: Effects of aerobic exercise on selected physiological parameters and quality of life in patients with type 2 diabetes mellitus. Int J Gen Med. 4:723–727. 2011. View Article : Google Scholar : PubMed/NCBI
37	Grisé KN, Olver TD, McDonald MW, Dey A, Jiang M, Lacefield JC, Shoemaker JK, Noble EG and Melling CW: High intensity aerobic exercise training improves deficits of cardiovascular autonomic function in a rat model of type 1 diabetes mellitus with moderate hyperglycemia. J Diabetes Res. 2016:81645182016. View Article : Google Scholar : PubMed/NCBI
38	Segura-Egea JJ, Castellanos-Cosano L, Machuca G, López-López J, Martín-González J, Velasco-Ortega E, Sánchez-Domínguez B and López-Frías FJ: Diabetes mellitus, periapical inflammation and endodontic treatment outcome. Med Oral Patol Oral Cir Bucal. 17:e356–e361. 2012. View Article : Google Scholar : PubMed/NCBI
39	Llauradó G, Gallart L, Tirado R, Megia A, Simón I, Caixàs A, Giménez-Palop O, Berlanga E, Vendrell J and González-Clemente JM: Insulin resistance, low-grade inflammation and type 1 diabetes mellitus. Acta Diabetol. 49:33–39. 2012. View Article : Google Scholar : PubMed/NCBI
40	Toupchian O, Sotoudeh G, Mansoori A, Djalali M, Keshavarz SA, Nasli-Esfahani E, Alvandi E and Koohdani F: Effects of DHA supplementation on vascular function, telomerase activity in PBMC, expression of inflammatory cytokines, and PPARγ-LXRα-ABCA1 pathway in patients with type 2 diabetes mellitus: Study protocol for randomized controlled clinical trial. Acta Med Iran. 54:410–417. 2016.PubMed/NCBI
41	Hong SB, Lee JJ, Kim SH, Suh YJ, Han JY, Kim YS and Nam M: The effects of adiponectin and inflammatory cytokines on diabetic vascular complications in obese and non-obese patients with type 2 diabetes mellitus. Diabetes Res Clin Pract. 111:58–65. 2016. View Article : Google Scholar : PubMed/NCBI
42	Cherney DZ, Scholey JW, Daneman D, Dunger DB, Dalton RN, Moineddin R, Mahmud FH, Dekker R, Elia Y, Sochett E and Reich HN: Urinary markers of renal inflammation in adolescents with type 1 diabetes mellitus and normoalbuminuria. Diabet Med. 29:1297–1302. 2012. View Article : Google Scholar : PubMed/NCBI
43	Tong HV, Luu NK, Son HA, Hoan NV, Hung TT, Velavan TP and Toan NL: Adiponectin and pro-inflammatory cytokines are modulated in Vietnamese patients with type 2 diabetes mellitus. J Diabetes Investig. 8:295–305. 2017. View Article : Google Scholar : PubMed/NCBI
44	Özçaka Ö, Ceyhan-Öztürk B, Gümüş P, Akcalı A, Nalbantsoy A and Buduneli N: Clinical periodontal status and inflammatory cytokines in gestational diabetes mellitus. Arch Oral Biol. 72:87–91. 2016. View Article : Google Scholar : PubMed/NCBI
45	Hopmans TE, van Houten C, Kasius A, Kouznetsova OI, Nguyen LA, Rooijmans SV, Voormolen DN, van Vliet EO, Franx A and Koster MP: Increased risk of type II diabetes mellitus and cardiovascular disease after gestational diabetes mellitus: A systematic review. Ned Tijdschr Geneeskd. 159:A80432015.(In Dutch). PubMed/NCBI
46	McDonald MW, Murray MR, Grise KN, Olver TD, Dey A, Shoemaker JK, Noble EG and Melling CW: The glucoregulatory response to high-intensity aerobic exercise following training in rats with insulin-treated type 1 diabetes mellitus. Appl Physiol Nutr Metab. 41:631–639. 2016. View Article : Google Scholar : PubMed/NCBI
47	Shang M, Zhao J, Yang L and Lin L: Oxidative stress and antioxidant status in women with gestational diabetes mellitus diagnosed by IADPSG criteria. Diabetes Res Clin Pract. 109:404–410. 2015. View Article : Google Scholar : PubMed/NCBI
48	Vural M, Camuzcuoglu H, Toy H, Cece H, Aydin H, Eren MA, Kocyigit A and Aksoy N: Evaluation of the future atherosclerotic heart disease with oxidative stress and carotid artery intima media thickness in gestational diabetes mellitus. Endocr Res. 37:145–153. 2012. View Article : Google Scholar : PubMed/NCBI
49	Horváth EM, Mágenheim R, Domján BA, Ferencz V, Tänczer T, Szabó E, Benkő R, Szabó C, Tabák Á and Somogyi A: The severity of gestational diabetes mellitus affects microvascular dysfunction measured three years after pregnancy that may be related to increased oxidative stress. Orv Hetil. 156:1932–1936. 2015.(In Hungarian). View Article : Google Scholar : PubMed/NCBI
50	Zhou H, Harberts E, Fishelevich R and Gaspari AA: TLR4 acts as a death receptor for ultraviolet radiation (UVR) through IRAK-independent and FADD-dependent pathway in macrophages. Exp Dermatol. 25:949–955. 2016. View Article : Google Scholar : PubMed/NCBI
51	Malgorzata-Miller G, Heinbockel L, Brandenburg K, van der Meer JW, Netea MG and Joosten LA: Bartonella quintana lipopolysaccharide (LPS): Structure and characteristics of a potent TLR4 antagonist for in-vitro and in-vivo applications. Sci Rep. 6:342212016. View Article : Google Scholar : PubMed/NCBI
52	Zhang Y, Zhu X, Feng Y, Pang W, Qi Z, Cui L and Cao Y: TLR4 and TLR9 signals stimulate protective immunity against blood-stage plasmodium yoelii infection in mice. Exp Parasitol. 170:73–81. 2016. View Article : Google Scholar : PubMed/NCBI
53	Murdock JL and Núñez G: TLR4: The winding road to the discovery of the LPS receptor. J Immunol. 197:2561–2562. 2016. View Article : Google Scholar : PubMed/NCBI
54	Feng K, Zhou GQ, Zhai Y, Zhu PF, Wang ZG, He FC and Jiang JX: Study on single nucleotide polymorphism of TLR4 in Chinese population. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 22:99–101. 2005.(In Chinese). PubMed/NCBI
55	Kawamoto EM, Cutler RG, Rothman SM, Mattson MP and Camandola S: TLR4-dependent metabolic changes are associated with cognitive impairment in an animal model of type 1 diabetes. Biochem Biophys Res Commun. 443:731–737. 2014. View Article : Google Scholar : PubMed/NCBI
56	Dong B, Qi D, Yang L, Huang Y, Xiao X, Tai N, Wen L and Wong FS: TLR4 regulates cardiac lipid accumulation and diabetic heart disease in the nonobese diabetic mouse model of type 1 diabetes. Am J Physiol Heart Circ Physiol. 303:H732–H742. 2012. View Article : Google Scholar : PubMed/NCBI
57	Manolakis AC, Kapsoritakis AN, Tiaka EK, Sidiropoulos A, Gerovassili A, Satra M, Vamvakopoulou D, Tsiopoulos F, Papanas N, Skoularigis I, et al: TLR4 gene polymorphisms: Evidence for protection against type 2 diabetes but not for diabetes-associated ischaemic heart disease. Eur J Endocrinol. 165:261–267. 2011. View Article : Google Scholar : PubMed/NCBI
58	Lele RD: Pro-insulin, C peptide, glucagon, adiponectin, TNF alpha, AMPK: Neglected players in type 2 diabetes mellitus. J Assoc Physicians India. 30:35–40. 2010.
59	Papadimitriou A, Peixoto EB, Silva KC, de Faria Lopes JM and de Faria Lopes JB: Increase in AMPK brought about by cocoa is renoprotective in experimental diabetes mellitus by reducing NOX4/TGFβ-1 signaling. J Nutr Biochem. 25:773–784. 2014. View Article : Google Scholar : PubMed/NCBI
60	Yao L, Wan J, Li H, Ding J, Wang Y, Wang X and Li M: Resveratrol relieves gestational diabetes mellitus in mice through activating AMPK. Reprod Biol Endocrinol. 13:1182015. View Article : Google Scholar : PubMed/NCBI